dr. weber on dabrafenib/trametinib approval for melanoma
Published 9 years ago • 476 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
1:08
dr. weber on dabrafenib/trametinib versus vemurafenib/cobimetinib in melanoma
-
1:27
dr. weber on side effects of dabrafenib/trametinib in melanoma
-
0:18
copy of dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
1:04
dr. wilson on long-term data with dabrafenib plus trametinib in melanoma
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
-
1:05
dr. weber on the future of checkpoint inhibitors in melanoma
-
2:16
dr. rodabe n. amaria on dabrafenib plus trametinib in melanoma
-
6:16
dabrafenib plus trametinib for stage iii mutant melanoma
-
0:54
activity of dabrafenib/trametinib combo in patients with melanoma brain metastases
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma